Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selina M Luger

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Best Practice & Research. Clinical Haematology|December 1, 2011
Is a nadir bone marrow required and, if so, what to do with residual disease?Selina M Luger
Best Practice & Research. Clinical Haematology|November 30, 2019
Acute myeloid leukemia: How to treat the fit patient over age 75?Selina M Luger
Blood|March 20, 2025
Introduction to a How I Treat series on acute myeloid leukemiaSelina M Luger
Best Practice & Research. Clinical Haematology|November 21, 2017
How can one optimize induction therapy in AML?Selina M Luger
Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
Is blinatumomab now standard of care consolidation for patients with ALL?Selina M Luger
Hematology. American Society of Hematology. Education Program|January 18, 2011
Treating the elderly patient with acute myelogenous leukemiaSelina M Luger
Blood|June 12, 2025
Introduction to a Blood Spotlight series on acute myeloid leukemiaSelina M Luger
Best Practice & Research. Clinical Haematology|December 6, 2021
Is the current consolidation regimen for AML evidence-based?Selina M Luger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Consolidation Therapy for Acute Myeloid Leukemia: Defining a BenchmarkSelina M Luger
Current Opinion in Hematology|January 15, 2016
Revisiting maintenance therapy in acute myeloid leukemia with novel agentsJonathan Canaani, Selina M Luger
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Best Practice & Research. Clinical Haematology|December 1, 2011
Is a nadir bone marrow required and, if so, what to do with residual disease?Selina M Luger
Best Practice & Research. Clinical Haematology|November 30, 2019
Acute myeloid leukemia: How to treat the fit patient over age 75?Selina M Luger
Blood|March 20, 2025
Introduction to a How I Treat series on acute myeloid leukemiaSelina M Luger
Best Practice & Research. Clinical Haematology|November 21, 2017
How can one optimize induction therapy in AML?Selina M Luger
Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
Is blinatumomab now standard of care consolidation for patients with ALL?Selina M Luger
Hematology. American Society of Hematology. Education Program|January 18, 2011
Treating the elderly patient with acute myelogenous leukemiaSelina M Luger
Blood|June 12, 2025
Introduction to a Blood Spotlight series on acute myeloid leukemiaSelina M Luger
Best Practice & Research. Clinical Haematology|December 6, 2021
Is the current consolidation regimen for AML evidence-based?Selina M Luger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Consolidation Therapy for Acute Myeloid Leukemia: Defining a BenchmarkSelina M Luger
Current Opinion in Hematology|January 15, 2016
Revisiting maintenance therapy in acute myeloid leukemia with novel agentsJonathan Canaani, Selina M Luger
Pageof 17